HER2/Neu, the human epidermal growth factor-2 receptor, also referred to as Erb-b2, is gene amplified and overexpressed in this subset of cancers which are not typically sensitive to endocrine therapy (8, 9). The gene discussed is ERBB2; the disease is cancer.